Company intelligence / Profile preview

The Vertical Group

Summit, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

The Vertical Group itself is not a clinical company but a venture capital firm backing a diverse portfolio of companies at pre-clinical to commercial stage, with notable clinical results in cancer therapies, medical devices for vascular and neurovascular interventions, and platform technologies for protein detection, diagnostics, and cellular therapies[1][2][3].

Therapeutic areas: NephrologyEndocrinologyRheumatologyGastroenterologyNeurologyOtherOncology
Modalities: Small moleculeProteinMonoclonal antibodyBiologicDevicePolymer-drug conjugate therapyDiagnostic
Industry: Investors

Partnerships

GlaxoSmithKline (Oncomed)Bayer (Oncomed)Tornier (BioSET, Tepha)Becton Dickenson (ViaCyte)SurModics (ViaCyte)Aesculap (Tepha)Lifecell (Tepha)NMT Medical (Tepha)

Beyond the preview

Go deeper on The Vertical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Vertical Group.

Explore the full profile